"Healthcare Capital and Mergers, LLC (HCM) of Chicago were engaged to prepare a Business Valuation report as part of due diligence (annexed) - HCM's independent valuation of Medivet: $15,700,000"
Looks like the Fair Market Value of Medivet and Medivet America is split $4.184m & $11.516m respectively.
------------------------------
Page 6 in the annex states forecast revenue etc for Medivet (incl America):
Profit and Loss Summary: ($000s) ..............................................2011.......2012.........2013 Revenue*................................4,944.....4,958......23,107 Total Operating Expenses*.......4,479......3,753.....18,070 EBITDA*.....................................465.....1,205.......5,037
*The above revenue and EBITDA projections are from the client prepared business plan
------------------------------
Decent 2013 revenue projections & EBITDA, IMO. Will be huge for the SP if they can come close to hitting that mark. All pie in the sky, but promising nonetheless.
Not surprisingly it seems like a fair bit of the volume sitting on the bid side has been pulled today whilst all this information is being absorbed - Bid 1.13m /Ask 5.03m. Wouldn't be surprised to see the SP pull back to 1.5c ish until closer the date (or until more info becomes available.)
MLA Price at posting:
18.0¢ Sentiment: Hold Disclosure: Held
